“Association Between Interleukin-6 Levels, Rituximab Response, and Disease Activity in Patients With Rheumatoid Arthritis”. Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 25, no. 3, Aug. 2025, pp. 455-61, https://doi.org/10.32947/ajps.v25i3.1225.